<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2020-3-3729</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-3729</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТОДЫ ДИАГНОСТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DIAGNOSTIC METHODS</subject></subj-group></article-categories><title-group><article-title>Фенотипы артериального давления у пациентов молодого возраста с сахарным диабетом первого типа</article-title><trans-title-group xml:lang="en"><trans-title>Blood pressure phenotypes in young patients with type 1 diabetes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1126-4282</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кобалава</surname><given-names>Ж. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kobalava</surname><given-names>Zh. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кобалава Жанна Давидовна — доктор медицинских наук, профессор, заведующая кафедрой внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева, заведующая кафедрой внутренних болезней, кардиологии и клинической фармакологии</p><p>Москва</p><p>ORCID: 0000-0003-1126-4282</p></bio><bio xml:lang="en"/><email xlink:type="simple">zkobalava@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9323-4444</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ставцева</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stavtseva</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ставцева Юлия Владимировна — кандидат медицинских наук, ассистент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева</p><p>Москва</p><p>ORCID 0000-0001-9323-4444</p></bio><bio xml:lang="en"/><email xlink:type="simple">y.stavtseva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1756-7583</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Троицкая</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Troitskaya</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Троицкая Едена Алексеевна — кандидат медицинских наук, доцент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева</p><p>Москва</p><p>ORCID 0000-0003-1756-7583</p></bio><bio xml:lang="en"/><email xlink:type="simple">trelen@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2412-5986</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сафарова</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Safarova</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сафарова Айтен Фуад Кызы — доктор медицинских наук, профессор кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева</p><p>Москва</p></bio><bio xml:lang="en"/><email xlink:type="simple">aytensaf@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петросян</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrosyan</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петросян Ануш Егоровна — аспирант кафедры внутренних болезней с курсом кардиологии и функциональной диагностики имени академика В. С. Моисеева</p><p>Москва</p></bio><bio xml:lang="en"/><email xlink:type="simple">y.stavtseva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Российский университет дружбы народов</institution></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>31</day><month>01</month><year>2020</year></pub-date><volume>25</volume><issue>3</issue><fpage>3729</fpage><lpage>3729</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кобалава Ж.Д., Ставцева Ю.В., Троицкая Е.А., Сафарова А.Ф., Петросян А.Е., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Кобалава Ж.Д., Ставцева Ю.В., Троицкая Е.А., Сафарова А.Ф., Петросян А.Е.</copyright-holder><copyright-holder xml:lang="en">Kobalava Z.D., Stavtseva Y.V., Troitskaya E.A., Safarova A.F., Petrosyan A.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/3729">https://russjcardiol.elpub.ru/jour/article/view/3729</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить фенотипы артериального давления (АД) при клиническом и суточном измерении, определить их ассоциации с параметрами артериальной ригидности и оценить глобальный сердечно-сосудистый риск (ССР) у молодых пациентов с сахарным диабетом 1 типа (СД1).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В поперечное одноцентровое исследование включен 81 пациент с СД1 без анамнеза артериальной гипертонии (АГ) и других сердечнососудистых заболеваний (ССЗ) (39% мужчин, медиана возраста 27 лет, медиана длительности СД — 6 лет). Всем выполнялось рутинное клинико-лабораторное обследование, измерение клинического АД, 24-часовое суточное мониторирование АД периферического АД (BPLab Vasotens), оценка центрального АД и параметров артериальной ригидности методом аппланационной тонометрии. Фенотипы АД анализировали с учетом критериев диагностики АГ ESC/ESH 2018. Оценку ССР проводили по глобальной шкале 10-летнего риска (ESC 2019). Статистически значимым считали р&lt;0,05.</p></sec><sec><title>Результаты</title><p>Результаты. Частота истинной АГ составила 6,2%, скрытой — 38,3%. Изолированная ночная АГ отмечена у 30,7% пациентов с клиническим АД &lt;140/90 мм рт.ст. В подгруппе со скрытой АГ преобладали пациенты с нормальным клиническим АД (58,1%), скрытая АГ в большинстве случаев была изолированной диастолической (64,5%). Наличие скрытой АГ ассоциировано с более высокой каротидно-феморальной скоростью распространения пульсовой волны (кфСРПВ) (медиана 7,2 vs 6,3 м/с, р=0,002). Наиболее распространенными профилями ночного снижения систолического АД являлись нон-диппер (63,9%) и найт-пикер (16,6%). У 87,7% пациентов зарегистрирован высокий и очень высокий ССР.</p></sec><sec><title>Заключение</title><p>Заключение. АГ встречается у 44,5% молодых пациентов с СД1 и характеризуется высокой частотой скрытой, изолированной ночной АГ и нон-диппинга. Скрытая АГ ассоциирована с более высокой кфСРПВ. Высокий и очень высокий 10-летний ССР отмечен у 87,7%.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study phenotypes of clinic and 24-hour ambulatory blood pressure (BP), to determine their associations with arterial stiffness parameters, and to assess global cardiovascular risk (CVR) in young patients with type 1 diabetes (T1D).</p></sec><sec><title>Material and methods</title><p>Material and methods. The presented cross-sectional single-center study included 81 T1D patients without a history of hypertension (HTN) and other cardiovascular diseases (CVD) (men — 39%; median age — 27 years; median duration of T1D — 6 years). All participants underwent a routine clinical and laboratory testing, measurement of clinic and 24-hour ambulatory BP (BPLab Vasotens), assessment of central BP and arterial stiffness parameters using applanation tonometry technique. BP phenotypes were analyzed with diagnostic criteria for HTN by ESC/ESH 2018 guidelines. CVR was assessed using the SCORE 10-year risk calculator (ESC 2019). The differences were considered significant at p&lt;0,05.</p></sec><sec><title>Results</title><p>Results. The prevalence of true HTN was 6,2%, masked HTN — 38,3%. Isolated nocturnal HTN was revealed in 30,7% of patients with clinic BP &lt;140/90 mm Hg. The subgroup with masked HTN was dominated by patients with normal clinic BP (58,1%) and in most cases was characterized by isolated diastolic BP increase (64,5%). Masked HTN was associated with a higher carotid-femoral pulse wave velocity (PWV) (median — 7,2 versus 6,3 m/s, p=0,002). The most common profiles of nocturnal BP decrease were non-dipper (63.9%) and night-picker (16.6%). High and very high CVR was recorded in 87,7% of patients. Conclusion. Hypertension occurs in 44,5% of young patients with type 1 diabetes and is characterized by a high prevalence of masked isolated nocturnal HTN and non-dipping. Masked HTN is associated with a higher carotid-femoral PWV. High and very high 10-year CVR was recorded in 87,7% of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 1 типа</kwd><kwd>суточное мониторирование артериального давления</kwd><kwd>скрытая артериальная гипертония</kwd><kwd>артериальная ригидность</kwd><kwd>сердечно-сосудистый риск</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 1 diabetes</kwd><kwd>24-hour ambulatory blood pressure monitoring</kwd><kwd>masked hypertension</kwd><kwd>arterial stiffness</kwd><kwd>cardiovascular risk</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Diaz-Valencia PA, Bougneres P, Valleron AJ. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health. 2015;15:255. doi:10.1186/s12889-015-1591-y.</mixed-citation><mixed-citation xml:lang="en">Diaz-Valencia PA, Bougneres P, Valleron AJ. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health. 2015;15:255. doi:10.1186/s12889-015-1591-y.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Xu G, Liu B, Sun Y, et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ. 2018;362:k1497. doi:10.1136/bmj.k1497.</mixed-citation><mixed-citation xml:lang="en">Xu G, Liu B, Sun Y, et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ. 2018;362:k1497. doi:10.1136/bmj.k1497.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова М.В., Викулова О.К., Железнякова А.В. и др. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;91(10):4-13. doi:10.26442/00403660.2019.10.000364.</mixed-citation><mixed-citation xml:lang="en">Shestakova MV, Vikulova OK, Zheleznyakova AV, et al. Diabetes epidemiology in Russia: what has changed over the decade? Therapeutic Archive. 2019;91(10):4-13. (In Russ.). doi:10.26442/00403660.2019.10.000364.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Schofield J, Ho J, Soran H. Cardiovascular Risk in Type 1 Diabetes Mellitus. Diabetes Ther. 2019;10(3):773-89. doi:10.1007/s13300-019-0612-8.</mixed-citation><mixed-citation xml:lang="en">Schofield J, Ho J, Soran H. Cardiovascular Risk in Type 1 Diabetes Mellitus. Diabetes Ther. 2019;10(3):773-89. doi:10.1007/s13300-019-0612-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">de Ferranti SD, de Boer IH, Fonseca V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014;130(13):1110-30. doi:10.1161/CIR.0000000000000034.</mixed-citation><mixed-citation xml:lang="en">de Ferranti SD, de Boer IH, Fonseca V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014;130(13):1110-30. doi:10.1161/CIR.0000000000000034.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Collado-Mesa F, Colhoun HM, Stevens LK, et al. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study. Diabet Med. 1999;16(1):41-8. doi:10.1046/j.1464-5491.1999.00007.x.</mixed-citation><mixed-citation xml:lang="en">Collado-Mesa F, Colhoun HM, Stevens LK, et al. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study. Diabet Med. 1999;16(1):41-8. doi:10.1046/j.1464-5491.1999.00007.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Maahs DM, Kinney GL, Wadwa P, et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28(2):301-6. doi:10.2337/diacare.28.2.30.1</mixed-citation><mixed-citation xml:lang="en">Maahs DM, Kinney GL, Wadwa P, et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28(2):301-6. doi:10.2337/diacare.28.2.30.1</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19(5):403. doi:10.1161/01.hyp.19.5.403.</mixed-citation><mixed-citation xml:lang="en">Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19(5):403. doi:10.1161/01.hyp.19.5.403.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Национальные клинические рекомендации “Диагностика и лечение пациентов с хронической обструктивной болезнью легких и артериальной гипертензией” 2017 г. https://www.rnmot.ru/public/uploads/RNMOT/clinical/2017/ХОБЛ%20и%20АГ%20Малявин_250618.pdf</mixed-citation><mixed-citation xml:lang="en">National clinical guidelines Diagnosis and treatment of patients with chronic obstructive pulmonary disease and hypertension 2017. (In Russ.) https://www.rnmot.ru/public/uploads/RNMOT/clinical/2017/ХОБЛ%20и%20АГ%20Малявин_250618.pdf</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues TC, Canani LH, Viatroski RS, et al. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract. 2010;87:240-5. doi:10.1016/j.diabres.2009.10.016</mixed-citation><mixed-citation xml:lang="en">Rodrigues TC, Canani LH, Viatroski RS, et al. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract. 2010;87:240-5. doi:10.1016/j.diabres.2009.10.016</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mateo-Gavira I, Vilchez-Lopez FJ, Garcia-Palacios MV, et al. Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complicat. 2016;30:1326-32. doi:10.1016/j.jdiacomp.2016.05.021.</mixed-citation><mixed-citation xml:lang="en">Mateo-Gavira I, Vilchez-Lopez FJ, Garcia-Palacios MV, et al. Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus. J Diabetes Complicat. 2016;30:1326-32. doi:10.1016/j.jdiacomp.2016.05.021.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lithovius R, Gordin D, Forsblom C, et al. Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes, Diabetologia. 2018;61:1935-45. doi:10.1007/s00125018-4648-5.</mixed-citation><mixed-citation xml:lang="en">Lithovius R, Gordin D, Forsblom C, et al. Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes, Diabetologia. 2018;61:1935-45. doi:10.1007/s00125018-4648-5.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019;16(1):6-31. doi:10.26442/2075082X.2019.1.190179.</mixed-citation><mixed-citation xml:lang="en">Chazova IE, Zhernakova YuV, on behalf of the experts. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Systemic Hypertension. 2019;16(1):6-31. (In Russ.). doi:10.26442/2075082X.2019.1.190179.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006.</mixed-citation><mixed-citation xml:lang="en">Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">George B, Bantwal G, Ayyar V, Mathew V. Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls. J Diabetes Sci Technol. 2015;9:138-44. doi:10.1177/1932296814551982.</mixed-citation><mixed-citation xml:lang="en">George B, Bantwal G, Ayyar V, Mathew V. Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls. J Diabetes Sci Technol. 2015;9:138-44. doi:10.1177/1932296814551982.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">O’Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731-68. doi:10.1097/HJH.0b013e328363e964.</mixed-citation><mixed-citation xml:lang="en">O’Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731-68. doi:10.1097/HJH.0b013e328363e964.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Васюк Ю.А. Ю.А., Иванова С.В., Школьник Е.Л. и др. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике. Кардиоваскулярная терапия и профилактика. 2016;15(2):419. doi:10.15829/1728-8800-2016-2-4-19.</mixed-citation><mixed-citation xml:lang="en">Vasyuk YA, Ivanova SV, Shkolnik EL, et al. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention. 2016;15(2):4-19. (In Russ.) doi:10.15829/1728-8800-2016-2-4-19.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323. doi:10.1093/eurheartj/ehz486.</mixed-citation><mixed-citation xml:lang="en">Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323. doi:10.1093/eurheartj/ehz486.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Salles GF, Reboldi G, Fagard RH, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hypertension. 2016;67(4):693-700. doi:10.1161/HYPERTENSIONAHA.115.06981.</mixed-citation><mixed-citation xml:lang="en">Salles GF, Reboldi G, Fagard RH, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hypertension. 2016;67(4):693-700. doi:10.1161/HYPERTENSIONAHA.115.06981.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care. 1999;22:1722-7. doi:10.2337/diacare.22.10.1722.</mixed-citation><mixed-citation xml:lang="en">Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care. 1999;22:1722-7. doi:10.2337/diacare.22.10.1722.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkinson IB, MacCallum H, Rooijmans D, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93:441-8. doi:10.1093/qjmed/93.7.441.</mixed-citation><mixed-citation xml:lang="en">Wilkinson IB, MacCallum H, Rooijmans D, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93:441-8. doi:10.1093/qjmed/93.7.441.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Shah AS, Wadwa RP, Dabelea D, et al. Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2015;16:36774. doi:10.1111/pedi.12279.</mixed-citation><mixed-citation xml:lang="en">Shah AS, Wadwa RP, Dabelea D, et al. Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2015;16:36774. doi:10.1111/pedi.12279.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mattace-Raso F, Hofman A, Verwoert GC, et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010 Oct;31(19):2338-50. doi:10.1093/eurheartj/ehq165.</mixed-citation><mixed-citation xml:lang="en">Mattace-Raso F, Hofman A, Verwoert GC, et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010 Oct;31(19):2338-50. doi:10.1093/eurheartj/ehq165.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res. 2012;35(7):695-701. doi:10.1038/hr.2012.26.</mixed-citation><mixed-citation xml:lang="en">Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res. 2012;35(7):695-701. doi:10.1038/hr.2012.26.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-88. doi:10.1093/eurheartj/ehz455.</mixed-citation><mixed-citation xml:lang="en">Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-88. doi:10.1093/eurheartj/ehz455.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
